After a new study found that lecanemab, an experimental Alzheimer's drug developed by Eisai and Biogen, slowed cognitive and functional decline by 27% compared to a placebo, Alzheimer's patients have a renewed hope for an effective treatment—but experts still have unanswered questions about the drug.

FDA on Thursday approved a new drug to treat amyotrophic lateral sclerosis (ALS) from Amylyx Pharmaceuticals—the first new treatment for the disease in five years. And while ALS patients and advocates have praised the move, some health experts have voiced concerns about the drug's efficacy.

After a 64-year-old woman was diagnosed with Bell's palsy, she waited months for her symptoms to improve—but they never did. Then, doctors found a squamous-cell carcinoma growing in her facial nerve, Lisa Sanders writes for the New York Times Magazine.

Radio Advisory's Rachel Woods sat down with Walgreens Health Chief Clinical Officer Dr. Sashi Moodley to discuss the obstacles of being a disruptor in a crowded competitive field, building longitudinal relationships with patients instead of transactional, and Walgreens’s goal of becoming an equal player in the value-based care industry.

CDC launches pilot program to improve vaccine equity among monkeypox patients, Covid-19 vaccination temporarily lengthens patients' menstrual cycles, and more in this week's roundup of monkeypox and Covid-19 news.

The Biden administration on Tuesday debuted its plan to end hunger in the United States by 2030, in today's bite-sized hospital and health industry news from California, the District of Columbia, and Minnesota.

A new study tries to explain the "Mandela Effect," why some people are mosquito magnets, and more.